series-c-plus
Stage
2
Investors
About
QuantalX Neuroscience develops neurofunctional assessment technology, specifically the Delphi-MD device, which combines transcranial magnetic stimulation (TMS) and electroencephalography (EEG) to provide real-time brain health assessments. The device aids in diagnosing and monitoring neurological conditions by comparing patient brain responses to an age-correlated normative database.
Explore QuantalX Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.